Bert van der Vegt

Validation of a whole‐slide image‐based teleconsultation network

Alexi Baidoshvili, Nikolas Stathonikos, Gerard Freling, 2018, Histopathology.

Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

Bert van der Vegt, Gooitzen M van Dam, Matthijs D Linssen, 2018, Nature Communications.

Fluorescently labeled bevacizumab in human breast cancer: defining the classification threshold

Vasilis Ntziachristos, Sabrina Oliveira, Willem P. Th. M. Mali, 2017, European Conference on Biomedical Optics.

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast

Bert van der Vegt, J. Wesseling, G. D. de Bock, 2007, Annals of Surgical Oncology.

Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Vasilis Ntziachristos, Sabrina Oliveira, Bert van der Vegt, 2016, Clinical Cancer Research.

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement

Bert van der Vegt, Geertruida H de Bock, H. Hollema, 2018, Breast Cancer Research and Treatment.

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.

Vasilis Ntziachristos, Maximilian Koch, Sabrina Oliveira, 2016, Cancer research.